About: Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 24 August 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2010 (uk) im August 2010 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 24 August 2010 (en) artículu científicu espublizáu n'agostu de 2010 (ast)
publication date	wds:Q58619940-E9D8584A-9FA2-44B7-A4E1-A07E470AC94D
publication date	2010-08-24 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58619940-2F095C55-5B1F-4ABD-AABD-F0B6422E41B8
language of work or name	English
author name string	wds:Q58619940-376333AF-8DFE-46E2-8465-DD94435AEED1 wds:Q58619940-3E7A3A52-222E-42FF-AF2A-99977A3FAA7E wds:Q58619940-4097E125-DA23-44D5-88D2-A19FDF51BB18 wds:Q58619940-60E73E07-7B78-413B-B4C0-62DFFAB9B924 wds:Q58619940-8A770F52-5DAB-4849-B5F3-7157610C2E77 wds:Q58619940-8DC5C47F-B5DD-495A-AD26-22022AE3D007 wds:Q58619940-955EA895-9FCC-4D0B-8D1F-43374FAAC4E1
author name string	I Jolanda M de Vries Gosse J Adema Cornelis J A Punt Roger P M Sutmuller Nicole M Scharenborg Ina S Klasen H Mary-Lène H Brouwer
rdfs:label	Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (en) Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (nl)
skos:prefLabel	Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (en) Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (nl)
name	Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (en) Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients (nl)
author	wds:Q58619940-2891477D-E3CE-4EFB-BE6D-B811D12EB802 wds:Q58619940-48C54B0F-AD6A-49D3-BEC7-0CA15C2A8E92 wds:Q58619940-EAC60ABA-852C-4864-A013-197EE025711B wds:Q58619940-EBC84D4C-AB51-46A5-80C8-3D961CD0FC50
author	Carl Figdor Luuk B Hilbrands Willem J Lesterhuis Joannes F. M. Jacobs
title	wds:Q58619940-0D90D762-73A5-47EB-B867-2552195B033A
title	Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients (en)
page(s)	wds:Q58619940-087B00DD-B033-482C-9904-19762FB93D6A
page(s)	5067-5078
instance of	wds:Q58619940-49B19E39-057F-44C3-BECD-BA6B145E5A09
instance of	scholarly article
main subject	wds:Q58619940-00961327-78EA-4A28-8118-19EF02C2C9E6 wds:Q58619940-326C9A44-122C-4EB6-B99A-879A855CF975 wds:Q58619940-830339FC-FCDA-4696-91A4-491B31717BC8 wds:Q58619940-A330718E-7D64-4C91-925C-A167F94C0885 wds:Q58619940-D7AE866A-4223-4506-892B-0056F6904C3A
main subject	monoclonal antibody antibody Patients dendritic cell metastatic melanoma
PubMed ID	wds:Q58619940-1DE61F9E-B843-4B4B-947A-23D1B9241F72
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20736326
PubMed ID	20736326
published in	wds:Q58619940-28B641B7-29A9-4BFC-9C11-81E78D6DE10B
published in	Clinical Cancer Research
issue	wds:Q58619940-170C8FE1-3B4D-4F0A-A2A3-C41AAEA27AEB
volume	wds:Q58619940-4F7762E7-D5E4-4702-A3D9-6FF4D706B2ED
issue	20
volume	16
DOI	wds:Q58619940-0BA918BB-7CBE-4380-B14F-7FC969DD4079
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-10-1757
DOI	10.1158/1078-0432.CCR-10-1757
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58619940
is cites work of	Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters Multiple vaccinations: friend or foe. Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma Cancer immunotherapy--revisited HDAC inhibitors and immunotherapy; a double edged sword? Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy Translating tumor antigens into cancer vaccines Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic) A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma Clinical use of dendritic cells for cancer therapy. Optimal management of metastatic melanoma: current strategies and future directions Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model Immune evasion in acute myeloid leukemia: current concepts and future directions The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma Roles of regulatory T cells in cancer immunity Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Cancer testis antigen and immunotherapy Tumor evasion from T cell surveillance T-regulatory cells: key players in tumor immune escape and angiogenesis Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer Melanoma vaccines: developments over the past 10 years. A review of dendritic cell therapy for cancer: progress and challenges Colorectal cancer vaccines in clinical trials. Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software